-
Loading metrics
Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain
- Simone Rivolo,
- Manuela Di Fusco,
- Carlos Polanco,
- Amiee Kang,
- Devender Dhanda,
- Mirko Savone,
- Aristeidis Skandamis,
- Thitima Kongnakorn,
- Javier Soto
x
- Published: November 12, 2021
- https://doi.org/10.1371/journal.pone.0259251